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Abstract
Trichosporon spp. have recently emerged as signiﬁcant human pathogens. Identiﬁcation of these species is important, both for epidemiological
purposes and for therapeutic management, but conventional identiﬁcation based on biochemical traits is hindered by the lack of updates to
the species databases provided by the different commercial systems. In this study, 93 strains, or isolates, belonging to 16 Trichosporon species
were subjected to both molecular identiﬁcation using IGS1 gene sequencing and matrix-assisted laser desorption ionisation–time-of-ﬂight
(MALDI–TOF) analysis. Our results conﬁrmed the limits of biochemical systems for identifying Trichosporon species, because only 27 (36%)
of the isolates were correctly identiﬁed using them. Different protein extraction procedures were evaluated, revealing that incubation for
30 min with 70% formic acid yields the spectra with the highest scores. Among the six different reference spectra databases that were
tested, a speciﬁc one composed of 18 reference strains plus seven clinical isolates allowed the correct identiﬁcation of 67 of the 68 clinical
isolates (98.5%). Although until recently it has been less widely applied to the basidiomycetous fungi, MALDI–TOF appears to be a valuable
tool for identifying clinical Trichosporon isolates at the species level.
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Introduction
Trichosporon spp. are well recognized as causative agents of
white piedra, a benign cutaneous infection characterized by the
presence of irregular nodules in hairy regions [1]. However,
more recently, the Trichosporon genus has emerged as a
life-threatening opportunistic pathogen responsible for inva-
sive infections in immunosuppressed patients [2–5]. Dissem-
inated infection is their most common clinical picture [6,7].
Their reported mortality rates range between 50% and 80%,
eventually reaching 100% in onco-haematological patients with
persistent neutropenia [2,3,8].
To date, at least 17 different species have been considered
as aetiological agents of Trichosporon infections [8–10]. Species
identiﬁcation is important for epidemiological purposes and to
better deﬁne species-speciﬁc clinical associations [11,12]. In
addition, certain Trichosporon species may be more resistant to
antifungal drugs [8]. However, identifying Trichosporon species
may be difﬁcult because the databases based on commercial
biochemical systems lack some of the newly described species.
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Even the target to use for molecular identiﬁcation is the
subject of debate. Indeed, analysis of the ITS1 region and the
D1/D2 domain of the large subunit of rDNA can fail in the
identiﬁcation of Trichosporon species, because these sequences
may only represent 1% of the nucleotide divergence of closely
related species [13–15]. However, Sugita et al. [14] have
shown that IGS1 sequencing allows closely related species to
be distinguished and should be considered as the method of
choice for accurately identifying Trichosporon species.
Matrix-assisted laser desorption ionisation–time-of-ﬂight
(MALDI–TOF) mass spectrometry (MS) has recently emerged
as a powerful tool for identifying yeast species and some of the
species of ﬁlamentous fungi from the Ascomycota phylum [16–
18]. To the best of our knowledge, a single study has focused
on Trichosporon identiﬁcation using MS [19]. This study,
however, included IGS1 sequencing analysis for only a limited
number of strains [19].
In the present study, we used a large panel of well-char-
acterized strains and clinical isolates belonging to the main
pathogenic Trichosporon species to evaluate the performance of
MALDI–TOF for identifying clinical Trichosporon isolates.
Materials and Methods
Strains
Ninety-three Trichosporon strains were included (Table 1).
Nineteen of these were reference strains from the CBS
collection (http://www.cbs.knaw.nl/collections/Biolomics.aspx?
Table=Yeasts%202011). Seventy-four were clinical isolates
collected between 2004 and 2012, which were recovered
from different body sites (blood, urine, stools, skin and
respiratory tract) and maintained as frozen stocks at 80°C in
yeast-extract peptone dextrose medium. They belong to the
collections of large university hospitals in S~ao Paulo, Brazil, and
Paris, Tours, Reims, Bordeaux and Nantes in France. Their
initial identiﬁcation was based on their phenotypic traits
(arthrospores and positive urea test) and biochemical proﬁle
(obtained using either the 20AUX/ID32C panels or the
VITEK2 automated system) (Biomerieux, Marcy l’Etoile,
France) and/or the sequences of the internal transcribed
spacer 1 (ITS1) region or intergenic spacer 1 region of their
rDNA (IGS1) [14,20].
Matrix-assisted laser desorption ionisation–time-of-ﬂight
mass spectrometry identiﬁcation
Mass spectra were acquired using a Microﬂex LT MALDI–TOF
mass spectrometer (Bruker, Bremen, Germany). The post-
analytical procedures were conducted using Biotyper software
and its associated database version 3.0 (Bruker). Identiﬁcation
TABLE 1. Strains utilized in this study according to species,
phenotypic and genotypic identiﬁcation, country and strain
name.
Strain
name Country
Phenotypic
identiﬁcation
Molecular
identiﬁcation
MS
identiﬁcation
DLC4 Brazil Trichosporon
asahiia
T. asahiif T. asahii
DLC7g Brazil T. asahiia T. asahiif T. asahii
DLC9 Brazil T. asahiia T. asahiif T. asahii
DLC12 Brazil T. asahiia T. asahiif T. asahii
DLC14 Brazil T. asahiia T. asahiif T. asahii
IAL2 Brazil T. asahiia T. asahiif T. asahii
IAL5 Brazil T. asahiia T. asahiif T. asahii
IAL6 Brazil T. asahiia T. asahiif T. asahii
IAL7 Brazil T. asahiia T. asahiif T. asahii
IAL11 Brazil T. asahiia T. asahiif T. asahii
IAL12 Brazil T. asahiia T. asahiif T. asahii
F2201 France T. asahiia T. asahiif T. asahii
FT01 France T. asahiib ND T. asahii
FT02 France T. asahiib ND T. asahii
FHD01 France T. asahiic ND T. asahii
FKBCT01 France T. asahiic ND T. asahii
FSA02 France T. asahiic ND T. asahii
FNA01 France T. asahiia ND T. asahii
FNA02 France T. asahiia ND T. asahii
FNA03 France T. asahiia ND T. asahii
FNA04 France T. asahiia ND T. asahii
FNA05 France T. asahiid ND T. asahii
CBS8972g Israel NA T. asahiif T. asahii
CBS7631g France NA T. asahiif T. asahii
CBS2479 Japan NA T. asahiif T. asahii
DLC2 Brazil T. asahiia Trichosporon
inkinf
T. inkin
DLC3 Brazil T. asahiia T. inkinf T. inkin
DLC6 Brazil T. asahiia T. inkinf T. inkin
DLC11g Brazil T. asahiia T. inkinf T. inkin
DLC15 Brazil T. asahiia T. inkinf T. inkin
DLC16 Brazil T. asahiia T. inkinf T. inkin
F0302 France T. asahiia T. inkinf T. inkin
F2501 France T. inkinb T. inkinf T. inkin
F1001 France T. inkinb T. inkinf T. inkin
FR03 France T. inkinc ND T. inkin
FR05 France T. inkinc T. inkinf T. inkin
FR13 France Trichosporon
sp.d
T. inkinf T. inkin
FNA06 France T. inkinc T. inkine T. inkin
FNA07 France T. inkinc T. inkinf T. inkin
CBS7630g United
Kingdom
NA T. inkinf T. inkin
DLC10 Brazil Trichosporon
mucoidesa
Trichosporon
dermatisf
T. dermatis
F2101 France T. mucoidesa T. dermatisf T. dermatis
F1601 France T. mucoidesa T. dermatisf T. dermatis
F2401 France T. mucoidesa T. dermatisf T. dermatis
F2301 France T. mucoidesa T. dermatisf T. dermatis
F1801 France T. mucoidesa T. dermatisf T. dermatis
F1301 France T. mucoidesa T. dermatisf T. dermatis
F0801g France T. mucoidesa T. dermatisf T. dermatis
F1401 France T. mucoidesa T. dermatisf T. dermatis
F2801 France T. mucoidesa T. dermatisf T. dermatis
FR02 France T. mucoidesc T. dermatisf T. dermatis
FR04 France T. mucoidesc T. dermatisf T. dermatis
FR06 France T. mucoidesc T. dermatisf T. dermatis
FR11 France T. mucoidesc T. dermatisf T. dermatis
FR14 France T. mucoidesc T. dermatisf T. dermatis
FR15 France Trichosporon
sp.d
T. dermatisf T. dermatis
FR16 France T. mucoidesc T. dermatisf T. dermatis
FR21 France T. mucoidesc T. dermatisf T. dermatis
FR23 France T. mucoidesc T. dermatisf T. dermatis
FR25 France T. mucoidesc T. dermatisf T. dermatis
FR26 France T. mucoidesc T. dermatisf T. dermatis
FT03 France T. mucoidesb T. dermatisf T. dermatis
CBS10495g Argentine NA T. dermatisf T. dermatis
CBS2043g Germany NA T. dermatisf T. dermatis
F1901 France T. asahiia Trichosporon
faecalef
T. faecale
FSA03 France T. asahiib T. faecalef T. faecale
IAL03g Brazil T. asahiia T. faecalef T. faecale
IAL04 Brazil T. inkina T. faecalef T. faecale
CBS4828g Brazil NA T. faecalef T. faecale
F2701g France Trichosporon
sp.d
Trichosporon
jiroveciif
T. jirovecii
F2702 France Trichosporon
sp.d
T. jiroveciif T. jirovecii
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compatibility relies upon comparing a given spectrum against a
main spectra (MSP) database, and its value is expressed as a
logscore (LS). LS values vary between 0 and 3, with 0 indicating
no relationship and 3 indicating identical spectrum proﬁles.
According to the manufacturer’s recommendations, LS values
between 1.7 and 2 are acceptable for genus identiﬁcation, and
an LS value ≥2.0 is required for accurate species identiﬁcation.
Protein extraction protocols
Because the spectra that were generated using intact cells
exhibited only a limited number of peaks (data not shown), we
ﬁrst compared three different protein extraction protocols to
determine which led to spectra with the highest logscores. The
isolates were slant-subcultured on Sabouraud dextrose agar
containing chloramphenicol and gentamicin (BioRad, Mar-
nes-la-Coquette, France) for 48 h at 30°C. All three of the
tested protocols relied on the extraction efﬁcacy of ethanol
70% and formic acid 70% (FA) plus acetonitrile 100% (ACN)
for the colonies harvested from the slant cultures. The ﬁrst
protocol followed the manufacturer’s recommendations for
yeast identiﬁcation. The second and third protocols were
recently published by Cassagne et al. [16] and Sendid et al.
[21], respectively. They differed in the time of the initial
centrifugation, the time of incubation, the volumes of FA and
ACN that were used and the volume of the ﬁnal deposit on
the slide (Table S1).
To compare the performances of the protocols, three MSP
libraries (one for each extraction procedure) were built. Each
library contained ﬁve MSPs, one for each of the following
strains: Trichosporon dermatis F0801, Trichosporon montevideense
CBS8605, Trichosporon inkin CBS7630, T. dermatis CBS2043
and Trichosporon asahii CBS8972. Each MSP was created from
20 spectra that were obtained from four slant cultures (ﬁve
extractions per culture) using Biotyper software 3.0 with the
MSP standard method parameters. Each of the 20 raw spectra
composing an MSP was submitted for MS identiﬁcation and the
best-matched LS values were calculated, generating 100 LS
values per extraction protocol, which were then compared.
Comparison of different databases for identifying
Trichosporon isolates
The BioTyper vs. 3.0 database (database 1) contains 11 MSPs,
which represent six different species. To enlarge this spectrum
of species, we created MSPs for 18 CBS reference strains and
seven clinical isolates of 16 species that had been identiﬁed
through the sequences of the IGS1 region (Table S2). Five
additional databases encompassing the MSPs of the reference
strains (database 2), combinations of databases 1 and 2, and
the MSPs of the clinical isolates were evaluated for the
identiﬁcation of the remaining 68 strains.
Protein extracts of the 68 strains that were not included in
the MSP database were tested in quadruplicate. For qualitative
analysis (i.e. correct or incorrect identiﬁcation at the genus
and species levels) only the spot returning the highest LS was
considered. For the 51 strains for which IGS1 rDNA region
was sequenced, the spectrometric identiﬁcation was consid-
ered correct if the results of both methods were congruent.
For the remaining 17 strains, the spectrometric identiﬁcation
was considered correct if the BioTyper analysis returned an LS
of greater than 2 for only one species.
Statistical analysis
The statistical analyses were performed using Prism software,
version 6.0 (GraphPad Software, La Jolla, CA, USA). The LSs
obtained using each extraction protocol were compared
using the non-parametric rank sum Kruskal–Wallis test. In the
case of a signiﬁcant difference, a post-hoc analysis was
conducted using pairwise matched Dunn’s tests with adjust-
ment for multiple comparisons. In every case, two-sided tests
were utilized and a p value of <0.05 was considered
signiﬁcant.
Table 1 (Continued)
Strain
name Country
Phenotypic
identiﬁcation
Molecular
identiﬁcation
MS
identiﬁcation
F2601 France Trichosporon
sp.d
T. jiroveciif T. jirovecii
FSA01 France Trichosporon
sp.d
T. jiroveciif T. jirovecii
CBS6864g Czech
Republic
NA T. jiroveciif T. jirovecii
F0501g France T. inkina Trichosporon
montevideensef
T. montevideense
F0701 France T. inkina T. montevideensef T. montevideense
FR01 France T. asahiic ND T. montevideense
CBS8605g Netherlands NA T. montevideensef T. montevideense
FR29g France T. asahiic Trichosporon
coremiiformef
T. coremiiforme
FR31 France Trichosporon
sp.d
ND T. coremiiforme
CBS2482g Costa Rica NA T. coremiiformef T. coremiiforme
FR12 France T. mucoidesc T. mucoidesf T. mucoides
CBS7625g Belgium NA T. mucoidesf T. mucoides
FR07 France T. inkinc ND Trichosporon
lactis
CBS9051g Austria NA T. lactisf T. lactis
FBOR01 France Trichosporon
sp.d
Trichosporon
loubierie
T. loubieri
CBS7719g Australia NA T. loubierif T. loubieri
CBS7556g Italy NA Trichosporon
ovoidesf
T. ovoides
CBS2466g France NA Trichosporon
cutaneumf
T. cutaneum
CBS8280g Japan NA Trichosporon
domesticumf
T. domesticum
CBS8641g Japan NA Trichosporon
japonicumf
T. japonicum
CBS9756g Germany NA Trichosporon
mycotoxinovoransf
T. mycotoxinovorans
CBS2481g Switzerland NA Trichosporon
asteroidesf
T. asteroides
aIdentiﬁcation using the VITEK2 system (Biomerieux, Marnes-la-Coquette, France).
bIdentiﬁcation using the API 20 AUX system (Biomerieux).
cIdentiﬁcation using the API 32 ID system (Biomerieux).
dIdentiﬁcation based on arthrospores and positive urease test.
eIdentiﬁcation using ITS1 rDNA sequencing.
fIdentiﬁcation using IGS1 rDNA sequencing.
gStrains included in main spectrum databases.
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Results
Performance of biochemical-based identiﬁcation
Phenotypic identiﬁcation led to a high number of mis- or
non-identiﬁcations (Table 1). All isolates of T. dermatis were
misidentiﬁed as T. mucoides. In addition, half (seven of 14) of
the T. inkin isolates were misidentiﬁed as T. asahii. Misidentif-
ication as T. asahii or T. inkin was also noted for Trichosporon
faecale (n = 4), T. montevideense (n = 3), Trichosporon coremii-
forme (n = 1) and Trichosporon lactis (n = 1). Finally, all of the
Trichosporon jirovecii isolates (n = 4) were not identiﬁed at the
species level but had only a genus characterization.
Protein extraction protocol
Three different protein extraction protocols were compared
for their ability to generate high LSs (Fig. 1). A signiﬁcant
difference in the performance of these protocols (p 0.014) was
observed. A post hoc analysis revealed that protocol 3
performed better than protocol 1 (p 0.012) but not protocol
2 (p 0.86) and that protocol 1 and protocol 2 performed
similarly (p 0.2). Because protocol 3 provided more homoge-
neous results than the other methods, it was selected for
further experiments.
Comparison of the main spectra databases for species
identiﬁcation
The performances of the six databases that were tested for
Trichosporon species identiﬁcation are summarized in Fig. 2.
The Biotyper 3.0 database (database 1) returned the lowest
level of correct identiﬁcation at the genus (85.1%) and the
species (31.3%) levels. In contrast, 100% identiﬁcation at the
genus level and 98.5% identiﬁcation at species level were
achieved using database 5, which contained 25 MSPs of
clinical and CBS strains. The rate of identiﬁcation with an LS
of >2.0 ranged from 28.36% (database 1) to 91.04%
(database 5).
Analysis using the BioTyper 3.0 database revealed misiden-
tiﬁcations (LS >1.7) for isolates of six species that are not
represented in the database (Table 2). This was particularly
the case for T. dermatis isolates (n = 21). In addition, ten
T. asahii isolates were identiﬁed as T. cutaneum. To dissect
these discrepancies, cross-identiﬁcation of the MSPs in the
Biotyper 3.0 database with those derived for the CBS strains
and the clinical isolates showed that T. cutaneum BioTyper
MSP(s) were identiﬁed as that/those of T. asahii, whereas the
Trichosporon ovoides BioTyper MSP was recognized as that of
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FIG. 1. Box-and-whiskers plot of the logscore values obtained using
the three extraction procedures tested in this study. Protocol 1:
Bruker’s recommended protocol for yeast identiﬁcation. Protocol 2:
described by Cassagne et al. [16]. Protocol 3: described by Sendid et al.
[21]. * Statistically signiﬁcant difference (p 0.012).
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FIG. 2. Distribution of the logscore (LS) values for 68 strains
obtained using matrix-assisted laser desorption ionisation–time-of-
ﬂight (MALDI–TOF), according to the reference main spectra (MSP)
databases that were searched. The dark line represents the
best-matched LS values of the correct identiﬁcation results, whereas
the grey line shows the best-matched LS values of the misidentiﬁcation
results. (a) Biotyper 3.0, database 1: several incorrect identiﬁcations
with LS values below 1.6 (mainly related to the absence of the species
in the main spectra (MSP) database) and with LS values above 2.0
(MSPs with incorrect identiﬁcation); (b) CBS strains, database 2; (c)
Biotyper 3.0 and CBS strains, database 3; (d) Biotyper 3.0 and clinical
strains, database 4; (e) CBS and clinical strains, database 5; (f) Biotyper
3.0, CBS and clinical strains, database 6. Databases 5 and 6 yielded the
best results, but incorrect identiﬁcations of Trichosporon dermatis as
Trichosporon mucoides with LS values above 2.0 were noted for one and
three isolates, respectively.
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T. dermatis. Similarly, the database composed using CBS strains
only (database 2) misidentiﬁed seven isolates of T. dermatis as
T. mucoides and one T. inkin isolate as T. ovoides.
Interestingly, misidentiﬁcations resulting from using data-
base 2 led us to sequence the IGS1 region of the strain
CBS10495, originally described as T. mucoides but found to be
T. dermatis after ﬁnal identiﬁcation (GenBank accession num-
ber AB066412.1). Finally, one isolate (FR16) that was identiﬁed
as T. mucoides using the MALDI-TOF results to search
database 5 (LS = 2.549) had 99% identity with T. dermatis
according to its IGS1 rDNA sequences (GenBank accession
number JF302985.1). However, using a multilocus phylogenetic
approach, the strain was found to be closely related to
T. mucoides (Congress of the French Society of Medical
Mycology, Dijon, 16–17 May 2013, abstract 15).
Discussion
Trichosporon spp. have recently emerged as life-threatening
opportunistic pathogens [8]. Species identiﬁcation in this
genus that would allow the description of possible new
epidemiological traits and would facilitate the difﬁcult deci-
sion-making regarding an antifungal strategy has become a
challenging issue. Biochemical proﬁling methods appear clearly
insufﬁcient for the reliable identiﬁcation of Trichosporon
species, even if, due to the heterogeneous phenotypic
methods utilized for the initial characterization, a one to
one comparison with the molecular or proteomic identiﬁca-
tion was not possible. In contrast, MALDI–TOF MS has
emerged as a powerful and reliable tool for the identiﬁcation
of fungi [22,23]. Some of these studies included a small
number of Trichosporon isolates [21,22,24–27]. For example,
Stevenson et al. [24] included nine species for an in-house
database construction, but did not include T. dermatis, for
which the distinction from T. mucoides is the most challenging.
More recently, Kolecka et al. [19] studied a large collection of
arthroconidial yeasts, including Trichosporon spp., using
MALDI–TOF MS. The overall rate of accurate species
identiﬁcation ranged from 95% (CBS strain collection) to
97% (clinical isolates). As in our study, discrepancies were
demonstrated for some of the clinically relevant, closely
related species, such as T. inkin/T. ovoides and T. mucoides/
T. dermatis. The frequency of these discrepancies may have
been underestimated in that study because (i) only T. asahii
strains were subjected to IGS1 sequencing and (ii) only a
limited number of T. mucoides/T. dermatis strains were tested;
this distinction appeared in our experience to be the most
challenging issue [19]. Thus, a robust database including
well-identiﬁed Trichosporon isolates (IGS1 rDNA sequenced)
representing the majority of species that are related to human
infections is required to identify the entire spectrum of
Trichosporon infections.
Although direct deposit of intact cells on the target plate is
the simplest method of sample processing, several authors
have stated that protein extraction provided better results
[21,26,27]. Similarly, the ‘smear procedure’ described by the
manufacturer was not achievable, because some of the isolates
produced colonies that were difﬁcult to homogeneously spot
onto the plate. In contrast, the extraction protocols previously
described [16,21] were shown to be powerful adjuncts for
MALDI-TOF analysis of Trichosporon species, allowing reliable
and reproducible results to be achieved. We believe that the
longer exposure to formic acid (30 min) was responsible for
the better results obtained using protocol 3, compared with
protocol 1. However, in routine practice, the additional
incubation period is time consuming, and protocol 2 may be
preferred.
Moreover, the reliability of the identiﬁcation was obviously
dependent on the MSP library that was used. The results
presented here showed that the manufacturer’s MSP library is
insufﬁcient to identify several of the Trichosporon species of
medical importance. This ﬁnding reﬂects this database’s lack
of MSPs for some of the common species, such as T. dermatis,
and the inclusion of MSPs for strains with probable erroneous
identiﬁcation. The former case has already been described
because some unusual species could be identiﬁed only after
the original MSP library was upgraded [28,29]. The latter
situation led to the misidentiﬁcation of 52.4% (11 out of 21)
of the T. asahii strains as T. cutaneum when the Bruker
Database
Spectrometric
identiﬁcation (number)
Logscore
range
Molecular
identiﬁcationa
MPS present in
the database (number)
Database 1
(Biotyper 3.0)
Trichosporon mucoides (n = 19) 1.709–2.477 Trichosporon dermatis No
Trichosporon ovoides (n = 2) 2.04–2.014 T. dermatis No
Trichosporon cutaneum (n = 10) 2.146–2.338 Trichosporon asahii Yes (2)
T. mucoides (n = 1) 1.864 Trichosporon jirovecii No
Database 2
(CBS strains)
T. mucoides (n = 6)b 2.36–2.467 T. dermatis Yes (2)
T. ovoides (n = 1) 1.754 Trichosporon inkin Yes (1)
aAs identiﬁed using IGS1 sequencing.
bOne of these strains (FR16) was later identiﬁed as Trichosporon mucoides using a multilocus approach (Congress of the
French Society of Medical Mycology, Dijon, 16–17 May 2013, abstract 15).
TABLE 2. Discordant results with
logscore values above 1.7 that were
obtained using databases 1 and 2
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database was used. We are not aware of any molecular data
concerning the two strains (120PSB and 95PSB) that were
used to generate the Biotyper MSP that is representative
of T. cutaneum. Stevenson et al. [24] also described the
erroneous identiﬁcation of several of the Trichosporon
reference strains. This was also the case for the CBS 10495
strain, described as T. mucoides based on ITS and D1/D2
regions sequencing but identiﬁed in this study as T. dermatis
based on IGS1 sequencing, in accordance with the MS
identiﬁcation.
Considering these different features, we were able to build
a speciﬁc database that allowed a 98.5% correct identiﬁcation
rate at the species level. The library contained 25 MSPs from
either the CBS strains or the clinical isolates that had a
deﬁnitive molecular-based identiﬁcation (IGS1 sequencing),
representing 16 different species. The recommendation that
each species should be represented by several isolates was
followed [16,24]. Interestingly, whereas misidentiﬁcations of
T. dermatis as T. mucoides using phenotypical or molecular
methods have been reported [11,12,15], our optimized
database unambiguously identiﬁed 21 isolates from both of
these species. Moreover, the single discrepancy found in this
study between IGS1 sequencing-based analysis, which provided
a 99% identity of the isolate as T. dermatis, and MALDI-TOF
MS-based analysis, which identiﬁed it as T. mucoides, referred
to an isolate that was related to T. mucoides using a multilocus
analysis. More strains of T. mucoides need to be studied to
conﬁrm this observation.
Using this database, we found that, consistent with previous
studies, T. asahii was the species that was most frequently
isolated from clinical specimens [12,30]. There are increasing
data supporting the existence of T. asahii isolates with high
minimal inhibitory concentrations for azole derivatives [8],
which are frequently used as the ﬁrst-line therapy, reinforcing
the need for methods that provide rapid and accurate
identiﬁcation of Trichosporon isolates. Thus, in addition to the
epidemiological importance of correct species identiﬁcation,
rapid and reliable identiﬁcation of T. asahii certainly will
facilitate the choice of an optimal antifungal therapy. Identiﬁ-
cation of fungal pathogens is essential, and our results illustrate
its importance in epidemiology and the prescription of the
appropriate antifungal therapy and possibly in taxonomic
studies. Revisiting the fungal epidemiological ﬁndings using
reliable identiﬁcation techniques is crucial to reveal the
pathogenic potential of species not currently considered
problematic and, conversely, to rule out some of the species
that were formerly considered pathogenic. MALDI–TOF MS
appears to be particularly suitable for investigating the
Trichosporon genus, but the Biotyper 3.0 database requires
improvement.
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